Experiencing a lingering cough after recovering from COVID-19? A post-COVID cough could simply be the residual effects of the illness, or it may signify something more serious such as lung cancer. In this article, OncoCare, a leading cancer centre in Singapore, discusses why individuals experience a post-COVID cough, how to recognise signs and symptoms associated with lung cancer, as well as address any risk factors related to prolonged coughing post-COVID that should not go unchecked.
Lung cancer is a daunting reality for millions of people across the globe, with smoking as its primary cause. However, it’s essential to note that non-smokers are not immune with lung cancer cases occurring regardless of whether or not someone has ever smoked before. This highlights how vital it is to educate ourselves on all aspects and risk factors behind this devastating disease, along with its resulting symptoms among those who have never lit up. By being informed of all this information as well as the prevention methods and treatments available, everyone can be better equipped to fight back against a common enemy – lung cancer.
Understanding all aspects of the diagnosis and treatment for lung cancer can seem daunting, but becoming educated about your condition is an essential part of your journey. If you have been diagnosed with lung cancer, chances are that you have heard about a brain MRI scan as one of the tests to evaluate it; however, you may still be wondering why this type of imaging test is necessary in this context. It may surprise you but a brain MRI can provide hugely important information when it comes to making decisions about your treatment plan.
One of the eye catching topics at the recent World Conference on Lung Cancer (WCLC) was about training dogs to sniff out malignant lung cancer nodules. The World Conference on Lung Cancer is the world’s largest meeting involving lung cancer specialists, researchers, doctors, from many countries, discussing about lung cancer and other thoracic malignancies. Several doctors from OncoCare Care Cancer Centre (Singapore) attended the meeting in September 2018.
The approach to management of advanced lung cancer has undergone a remarkable transformation over the past decade. This is due to the availability of a number of targeted agents in treatment of molecularly driven lung cancer subsets; as well as availability of immunotherapy agents.
Lung cancer can occur in non-smokers. The population trend in lung cancer is changing and this is increasingly recognized worldwide. In Asia, up to a third of lung cancer patients diagnosed are never smokers while the figures in West are lower. Intriguingly, there are differences between gender too. In one of the studies reported, approximately 15% of men compared with 60 to 80 percent of women with lung cancer were never-smokers!